CompletedPhase 4NCT01536158

Oral Paracetamol Versus Oral Ibuprofen in Management of Patent Ductus Arteriosus in Preterm Infants: A Randomised Controlled Trial

Studying Arterial duct anomaly

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Zekai Tahir Burak Women's Health Research and Education Hospital
Principal Investigator
Mehmet Yekta Oncel, MD
Zekai Tahir Burak Women's Health Research and Education Hospital
Intervention
Oral paracetamol(drug)
Enrollment
80 enrolled
Eligibility
All sexes
Timeline
20122012

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01536158 on ClinicalTrials.gov

Other trials for Arterial duct anomaly

Additional recruiting or active studies for the same condition.

See all trials for Arterial duct anomaly

← Back to all trials